Open AccessSerum Acylcarnitines and Risk of Cardiovascular Death and Acute Myocardial Infarction in Patients With Stable Angina Pectoris
Author(s) -
Strand Elin,
Pedersen Eva R.,
Svingen Gard F. T.,
Olsen Thomas,
Bjørndal Bodil,
Karlsson Therese,
Dierkes Jutta,
Njølstad Pål R.,
Mellgren Gunnar,
Tell Grethe S.,
Berge Rolf K.,
Svardal Asbjørn,
Nygård Ottar
Publication year - 2017
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.116.003620
Subject(s) - medicine , myocardial infarction , cardiology , diabetes mellitus , ejection fraction , hazard ratio , unstable angina , angina , body mass index , creatinine , heart failure , endocrinology , confidence interval
Excess levels of serum acylcarnitines, which are intermediate products in metabolism, have been observed in metabolic diseases such as type 2 diabetes mellitus. However, it is not known whether acylcarnitines may prospectively predict risk of cardiovascular death or acute myocardial infarction in patients with stable angina pectoris.